Pharmafile Logo
Pharmafocus logo
Advanced Search

Parkinson’s

Showing 6 posts of 36 posts found.

Phytopharm suffers Parkinson’s loss

February 20, 2013
Research and Development, Sales and Marketing Parkinson's, Phytopharm, cogane

Phytopharm is facing an uncertain future after the failure of one of its most promising drugs in a Phase II …

News
Takeda HQ image

Takeda to buy Envoy Therapeutics

November 7, 2012
Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda

Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …

News

Parkinson’s specialist spins out from Merck Serono’s Swiss R&D ops

July 30, 2012
Research and Development, Sales and Marketing Merck Serono, Parkinson's, Prexton, Swiss

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …

News

UCB signs Parkinson’s research deal

October 12, 2010
Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology

UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease.  Basel-based Synosia has …

News

Roche signs Alzheimer’s deal with reMYND

September 7, 2010
Research and Development Alzheimer's, Parkinson's, Roche, reMYND

Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …

News

Pharma pools trial data for brain disorder research

June 14, 2010
Research and Development Alzheimer's, Huntington's, Parkinson's, clinical trials, partnerships

Leading pharma companies have come together for a major new research collaboration aimed at improving clinical trials for Alzheimer’s, Parkinson’s, …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026